ArticleAnnals of surgical oncology2026
Does Multidisciplinary Clinic Impact Rates of Breast Conserving Therapy?
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have identified factors associated with higher rates of breast conservation therapy (BCT), but the impact of multidisciplinary clinic (MDC) has not been documented. We hypothesized that patients who underwent MDC consultation with both surgical and radiation oncologists would have increased BCT rates compared with patients seeing providers separately. PATIENTS AND
methodsA retrospective chart review was conducted in patients diagnosed with stage 0-III breast cancer in 2023 who were offered BCT. Patients were separated into four cohorts on the basis of initial clinical consultation: (1) three-provider MDC with Breast Surgical Oncology (BSO), Medical Oncology (MO), Radiation Oncology (RO); (2) BSO+RO in MDC; (3) BSO+MO in MDC; and (4) BSO only. Wilcoxon Rank Sum tests and Chi-Square or Fisher's Exact tests were used to compare clinicopathologic factors and the primary outcome of interest (BCT versus mastectomy) between cohorts with p < 0.05 considered statistically significant.
resultsThe type of initial consultation was significantly associated with differing BCT rates (p = 0.015). Specifically, BCT was highest for patients participating in three-provider MDC (BCT rate 89%), and BSO+RO in MDC (BCT rate 86%). In contrast, BCT was lower when patients did not see RO in MDC, including patients seen by both BSO+MO in MDC (BCT rate 78%) and BSO alone (BCT rate 77%).
conclusionsOur study confirms that MDC consultations that include RO are associated with higher BCT rates. Broader implementation of MDC with RO alongside BSO may support BCT acceptance in eligible patients through more effective patient education and shared decision-making.
Indexed as
Identifiers
41703206What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.